A detailed history of Globeflex Capital L P transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 467,772 shares of ADMA stock, worth $9.09 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
467,772
Previous 478,146 2.17%
Holding current value
$9.09 Million
Previous $3.16 Million 65.74%
% of portfolio
0.55%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.98 - $11.18 $62,036 - $115,981
-10,374 Reduced 2.17%
467,772 $5.23 Million
Q1 2024

May 14, 2024

BUY
$4.4 - $6.74 $934,560 - $1.43 Million
212,400 Added 79.93%
478,146 $3.16 Million
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $98,852 - $145,069
32,095 Added 13.74%
265,746 $1.2 Million
Q3 2023

Nov 13, 2023

SELL
$3.47 - $4.61 $9,271 - $12,317
-2,672 Reduced 1.13%
233,651 $836,000
Q1 2023

May 12, 2023

BUY
$3.01 - $3.87 $711,332 - $914,570
236,323 New
236,323 $782,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.82B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.